ELTP
Elite Pharmaceuticals, Inc.

3,242
Mkt Cap
$409.15M
Volume
352,317.00
52W High
$0.8194
52W Low
$0.27
PE Ratio
17.43
ELTP Fundamentals
Price
$0.3799
Prev Close
$0.3779
Open
$0.378
50D MA
$0.4033
Beta
0.58
Avg. Volume
672,887.77
EPS (Annual)
-$0.004
P/B
5.08
Rev/Employee
$1.24M
$464.31
Loading...
Loading...
News
all
press releases
The Zacks Analyst Blog Highlights GE Aerospace, Shell, McKesson, Elite Pharmaceuticals and Geospace Technologies
GE, SHEL and MCK lead Zacks picks, driven by strong demand, cash flow growth and strategic expansion despite cost and market risks.
Zacks·19d ago
News Placeholder
More News
News Placeholder
Top Stock Reports for GE Aerospace, Shell & McKesson
GE Aerospace gains on strong engine demand and defense tailwinds, while Shell and McKesson navigate mixed performance and strategic shifts.
Zacks·19d ago
News Placeholder
Elite Pharmaceuticals Stock Dips Post Q3 Earnings Despite Revenue Jump
ELTP reports surging revenue and profit in third-quarter fiscal 2026, but margin pressure and M&A ambitions steal the spotlight.
Zacks·1mo ago
News Placeholder
ELTP Stock Declines Despite Solid Q2 Earnings and Revenue Performance
Elite Pharmaceuticals delivers record second-quarter fiscal 2026 earnings as lisdexamfetamine sales surged, though margins faced competitive pressure.
Zacks·5mo ago
News Placeholder
The Zacks Analyst Blog Highlights Berkshire Hathaway, Toyota Motor, McDonald's, Elite Pharmaceuticals and BK Technologies
Zacks highlights Berkshire Hathaway, Toyota, McDonald's, Elite Pharma and BK Technologies as diverse plays with unique growth catalysts and risks.
Zacks·7mo ago
News Placeholder
Top Analyst Reports for Berkshire Hathaway, Toyota Motor & McDonald's
Analysts spotlight Berkshire, Toyota and McDonald's, highlighting growth drivers, risks and market performance in new research reports.
Zacks·7mo ago
News Placeholder
ELTP Stock Gains Following Q1 Earnings Showing Strong Revenue Growth
Elite Pharmaceuticals reports strong first-quarter fiscal 2026 results with rising direct sales, higher-margin products and expanding gross profit.
Zacks·8mo ago
News Placeholder
2 Outperform Rated Small Caps with Recent Pull-backs
ELTP and TSSI are growth stories with recent material pull-backs.
Zacks·8mo ago
News Placeholder
The Zacks Analyst Blog Highlights Cisco Systems, Caterpillar, Charles Schwab and Elite Pharmaceuticals
CSCO, CAT, SCHW and ELTP are driving gains with strong segment growth, strategic deals, and rising investor interest in key sectors.
Zacks·8mo ago
News Placeholder
Top Analyst Reports for Cisco, Caterpillar & Charles Schwab
CSCO, CAT and SCHW shares outperformed peers as analysts highlight growth drivers and risks in key business segments.
Zacks·9mo ago
<
1
2
...
>

Latest ELTP News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.